EP300 and neoplasm: CBP/p300 activates oncogene transcription and induces cancer cell proliferation, survival, tumorigenesis, metastasis, immune evasion, and drug-resistance, and was shown to be a poor prognostic linked with increased tumor recurrence [104,106,107].